SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-15-001049
Filing Date
2015-02-25
Accepted
2015-02-25 20:17:17
Documents
1
Period of Report
2015-02-23

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_142491342783929.html 4  
1 FORM 4 wf-form4_142491342783929.xml 4 3917
  Complete submission text file 0001628280-15-001049.txt   5322
Mailing Address 4660 LA JOLLA VILLAGE DRIVE, SUITE 1070 SAN DIEGO CA 92122
Business Address 4660 LA JOLLA VILLAGE DRIVE, SUITE 1070 SAN DIEGO CA 92122 858-207-4264
LA JOLLA PHARMACEUTICAL CO (Issuer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: CA | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O PURE BIOSCIENCE 1725 GILLESPIE WAY EL CAJON CA 92020
Business Address
Johnson Craig A (Reporting) CIK: 0001370348 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36282 | Film No.: 15649680